Zacks Research Analysts Reduce Earnings Estimates for THC

Tenet Healthcare Co. (NYSE:THC) – Equities research analysts at Zacks Research decreased their Q2 2026 EPS estimates for Tenet Healthcare in a research note issued on Wednesday, March 26th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $3.33 for the quarter, down from their prior estimate of $3.34. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q3 2026 earnings at $3.08 EPS.

THC has been the subject of several other research reports. StockNews.com upgraded shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, March 13th. Morgan Stanley initiated coverage on Tenet Healthcare in a research report on Wednesday, March 26th. They issued an “overweight” rating and a $165.00 price objective on the stock. The Goldman Sachs Group lowered Tenet Healthcare from a “buy” rating to a “neutral” rating and decreased their target price for the company from $196.00 to $140.00 in a research report on Monday, December 16th. KeyCorp reduced their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $177.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 13th. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $166.41.

Tenet Healthcare Price Performance

THC opened at $133.17 on Monday. Tenet Healthcare has a 1 year low of $90.03 and a 1 year high of $171.20. The company has a market capitalization of $12.67 billion, a price-to-earnings ratio of 4.13, a P/E/G ratio of 1.02 and a beta of 2.06. The firm’s fifty day moving average price is $132.43 and its two-hundred day moving average price is $142.31. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. New Wave Wealth Advisors LLC bought a new position in shares of Tenet Healthcare during the 4th quarter valued at $343,000. Swedbank AB boosted its holdings in shares of Tenet Healthcare by 100.0% during the fourth quarter. Swedbank AB now owns 40,000 shares of the company’s stock worth $5,049,000 after purchasing an additional 20,000 shares during the period. Signet Financial Management LLC purchased a new position in Tenet Healthcare during the 4th quarter valued at about $1,526,000. China Universal Asset Management Co. Ltd. purchased a new stake in Tenet Healthcare in the 4th quarter worth approximately $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of Tenet Healthcare during the fourth quarter valued at approximately $5,892,000. 95.44% of the stock is currently owned by institutional investors.

Insider Activity at Tenet Healthcare

In other news, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the transaction, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. This represents a 25.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.93% of the stock is owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.